Lukk

NO - NO


Please select a country and, if applicable, a language.

Artikkeloversikt

Practical guidance for the diagnosis and management of functional abdominal cramping pain


Functional abdominal cramping pain (FACP) is a common but presently under-recognised condition. Practical recommendations for FACP diagnosis and management are lacking. A recent publication based on a ...

Til artikkelen
Forfatter: Daniel Marquez, Harald Weigmann og Robert LangeEFSM: 2023;3:230020DOI: 10.52778/efsm.23.0020Dato: 25.08.2023

Combination of probiotics, plant extracts and micronutrients shows positive effects on the …


Functional disorders of the gastrointestinal tract cause symptoms that can have a significant impact on the quality of life. Maintaining an intact intestinal barrier is essential for preventing and tr ...

Til artikkelen
Forfatter: Dr. Stephan Barth, Giorgia Bulferi, Roberta Lanza, Heide De Togni og Floriana RasoEFSM: 2023;3:230011DOI: 10.52778/efsm.23.0011Dato: 24.07.2023

Real-world data confirm effectiveness of a thyme-ivy extract combination


From October 2019 to April 2020, the phytopharmaceutical Bronchipret® Drops, which contains a thyme-ivy extract combination (BNO 1200), was investigated in a large, practice-oriented, pharmacy-based o ...

Til artikkelen
Forfatter: Claudia B. BittnerEFSM: 2023;3:230009DOI: 10.52778/efsm.23.0009Dato: 29.01.2023

Efficacy and safety of fexofenadine in children with allergic rhinitis


Allergic rhinitis is the most common undiagnosed chronic condition in children and negatively affects sleep, school performance and leisure activities. Intranasal corticosteroids and oral antihistamin ...

Til artikkelen
Forfatter: Margarita Murrieta-Aguttes, MD, Mohamed Amessou, PhD, MBA og Michele Lheritier-Barrand, MDEFSM: 2023;3:230003DOI: 10.52778/efsm.23.0003Dato: 29.01.2023

Onychomycosis guideline update


Self-medication with antimycotic nail polishes plays an important role in Germany due to the numerous OTC drugs available and an increasing number of onychomycosis cases. Older patients in particular ...

Til artikkelen
Forfatter: Prof. Dr. med. Peter Mayser og Mareike NiehausEFSM: 2023;3:230001DOI: 10.52778/efsm.23.0001Dato: 02.01.2023

Onset of the neutralising action of antacids based on calcium and magnesium carbonate using an …

An in-vitro study


The in-vitro study evaluated the onset of the neutralising action of the antacid Rennie® as compared to a placebo. Among other things, the results showed a rise in the pH of the artificial stomach liq ...

Til artikkelen
Forfatter: Sandra Bartylla og Malte GrieswelleEFSM: 2022;2:220160DOI: 10.52778/efsm.22.0160Dato: 14.12.2022

Metamizole: A comprehensive approach to its benefit-risk profile


Metamizole is a drug with many years of use in some countries, and a large number of patients are exposed to its pharmacologic effects. The safety assessments have been done decades ago; therefore, it ...

Til artikkelen
Forfatter: Waltraud Stromer, PhD og Mariana Palladini, PhDEFSM: 2022;2:220153DOI: 10.52778/efsm.22.0153Dato: 02.11.2022

Circadian rhythm and its potential influence on gut motility


The gastrointestinal system exhibits circadian fluctuations in activity that are under control of central and peripheral mechanisms. Disturbance of such rhythms may be associated with symptoms like co ...

Til artikkelen
Forfatter: Robert Lange, PhD og Sabine Landes, PhDEFSM: 2022;2:220144DOI: 10.52778/efsm.22.0144Dato: 12.09.2022

Self-Healing concept for musculoskeletal pain management: An evidence-based review


International guidelines are commonly integrating complementary and integrative approaches into the management of musculoskeletal pain. This improves overall well-being while concomitantly reducing th ...

Til artikkelen
Forfatter: Bill Giannakopoulos, PharmD, Hayet Kechemir, MD, Mohamed Amessou, PhD og Iva Igracki Turudic, MDEFSM: 2022;2:220130DOI: 10.52778/efsm.22.0130Dato: 21.08.2022

Meta-analysis and narrative review confirm the benefit of essential phospholipids in non-alcoholic …


Non-alcoholic fatty liver disease (NAFLD), also known as metabolic associated fatty liver disease or MAFLD, is one of the most common liver diseases worldwide. Although NAFLD is associated with metabo ...

Til artikkelen
Forfatter: Lorena Petcu, MD og Branko Popovic, MDEFSM: 2022;2:220121DOI: 10.52778/efsm.22.0121Dato: 08.07.2022